查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571792

腎造口設備市場規模、佔有率、趨勢分析報告：依產品、最終用途、按地區、細分市場預測，2024-2030 年

Nephrostomy Devices Market Size, Share & Trends Analysis Report By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

腎造口設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球腎造口設備市場規模將達23.2億美元，2024年至2030年複合年成長率為7.9%。

醫生對腎造口設備的認知不斷提高，腎結石病例數量不斷增加，正在推動市場的發展。卵巢、膀胱癌和前列腺癌盛行率的增加以及新興經濟體醫療基礎設施的改善也是推動市場成長的主要因素。

由於腎結石疾病以及卵巢、膀胱癌和前列腺癌的盛行率不斷增加，北美預計將創下最高的市場佔有率。例如，根據美國癌症協會的數據，2018 年美國大約診斷出 22,240 例卵巢癌新病例。該市場的主要企業專注於新產品的發布和現有產品的創新。例如，2017年2月，庫克醫療推出了Universa，擁有兩套經皮泌尿裝置。

腎造口設備市場報告亮點

  • 導管導引線佔據市場主導地位，2023 年市場佔有率為 28.7%。這是由於老年人口的增加、醫院基礎設施的改善以及技術的進步。
  • 預計腎造口導管在預測期內將以顯著的複合年成長率成長。這是由於男性和女性腎結石和尿道感染的增加。
  • 醫院佔據市場主導地位，2023年市場佔有率為69.3%。醫院通常可以獲得腎造口技術的最新創新。
  • 2023 年，北美腎造口設備市場佔據主導地位。這是由於該地區慢性腎臟病的盛行率不斷上升。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 腎造口設備市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 腎造口設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 腎臟造口設備市場：產品估算與趨勢分析

  • 細分儀表板
  • 腎造口設備市場：2023 年及 2030 年產品變化分析
  • 導管導引線
  • 引流管
  • 腎造口導管
  • 鞘套管擴張器
  • 其他

第5章 腎臟造口設備市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 腎造口設備市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 急診室
  • 日間手術中心 (ASC)

第6章腎臟造口設備市場：區域估計與趨勢分析

  • 2023 年及 2030 年腎臟造口設備市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Teleflex Incorporated.
    • Cardinal Health.
    • BD
    • Cook Medical
    • B. Braun Melsungen AG
    • Coloplast Group
    • Olympus Corporation
    • Argon Medical Devices.
    • UreSil, LLC
簡介目錄
Product Code: GVR-3-68038-116-0

Nephrostomy Devices Market Growth & Trends:

The global nephrostomy devices market size is anticipated to reach USD 2.32 billion by 2030 registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.

North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.

Nephrostomy Devices Market Report Highlights:

  • Guidewires dominated the market and accounted for a market share of 28.7% in 2023. It can be attributed to the rising geriatric population, improved hospital infrastructure, and technological advancements.
  • Nephrostomy catheters are expected to grow at a significant CAGR over the forecast period. It can be attributed to the rising cases of kidney stones & urinary tract infections in both men and women.
  • Hospitals dominated the market and accounted for a market share of 69.3% in 2023. Hospitals typically have access to the latest innovations in nephrostomy technology.
  • North America nephrostomy devices market dominated in 2023. It can be attributed to the increasing prevalence of chronic kidney diseases in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nephrostomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nephrostomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nephrostomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nephrostomy Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Guidewires
    • 4.3.1. Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Drainage Tubes
    • 4.4.1. Drainage Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nephrostomy Catheters
    • 4.5.1. Nephrostomy Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sheath Dilators
    • 4.6.1. Sheath Dilators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nephrostomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nephrostomy Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Emergency Clinics
    • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nephrostomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Nephrostomy Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Teleflex Incorporated.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Cardinal Health.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. BD
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Cook Medical
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. B. Braun Melsungen AG
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Coloplast Group
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Olympus Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Argon Medical Devices.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. UreSil, LLC
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives